ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Status of Bard, Ethicon and Atrium Hernia Mesh Lawsuits


Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Hernia Mesh

Three medical device companies face 14,900 hernia lawsuits pending in three federal multidistrict litigations across the country. 

The COVID-19 pandemic has caused litigation delays in each MDL, and judges have rescheduled bellwether trials for 2021. There haven’t been any publicly reported settlements in these groups of litigation yet. 

In the meantime, lawsuit numbers continue to rise. 

C.R. Bard Trial Set for January 2021

As of October 2020, Bard faced 9,394 federal hernia mesh lawsuits in the Southern District of Ohio before Judge Edmund A. Sargus, Jr. 

The first bellwether trial date has been moved several times, and the COVID-19 pandemic has delayed it further. Steven Johns is the first Bard plaintiff scheduled for trial. 

Johns’ lawsuit claims he suffered severe complications after his surgeon implanted him with Bard Ventralight ST mesh. After his first surgery, he suffered pain, a hernia recurrence and adhesions. He had surgery to remove the original mesh and replace it with another Ventralight ST. 

Trials were originally supposed to start in May 2020. Then, they were rescheduled to September 2020. But because of the COVID-19 pandemic, Judge Sargus moved the first trial date to Jan. 11, 2021. 

In a pretrial order dated Aug. 14, 2020, Judge Sargus noted there may be 10,000 lawsuits against Bard by the time the first case goes to trial. The trial may be rescheduled again if the Court has a scheduling conflict. 

Plaintiffs filed a motion to exclude the defense expert testimony of Dr. Yuri William Novitsky and Dr. David B. Renton. Judge Sargus partially granted the motion in an order dated Sept. 11, 2020. He ruled the defense’s experts cannot say the device “is in no way defective” or that the warnings about complication risk were sufficient.

Injured by complications related to hernia mesh? Get a Free Case Review


Johnson & Johnson’s subsidiary Ethicon faces 3,128 Physiomesh hernia mesh lawsuits as of October 2020. Judge Richard Story presides over these cases in the Northern District of Georgia. 

In September 2020, four bellwether cases were selected. These include lawsuits filed by Diane and Jim Crumbley, Danielle Guffy, James Bovian and Jeffrey Smith.

The Crumbley’s lawsuit will be the first to go to trial. Jim Crumbley had Ethicon Physiomesh implanted in 2014. His lawsuit claims he had to have a second surgery for complications and still has complications. 

The trial is set for Jan. 25, 2021 and is expected to last two to three weeks. The second bellwether will begin on March 29, 2021, the third on June 7, 2021, and the fourth trial date has yet to be determined. 


As of October 2020, there are 2,378 Atrium C-QUR mesh lawsuits pending in an MDL in New Hampshire federal court before Judge Landya B. McCafferty. 

The first bellwether was originally scheduled for May 2020. In April, Atrium requested the trial date be pushed back to 2021 because of the pandemic. The judge granted the request.

Carrie Barron’s lawsuit will be the first bellwether and is scheduled for trial on Jan. 20, 2021. But prior to the trial, plaintiffs and defendants have a deadline of Oct. 26, 2020, for a potential settlement conference, according to a status agenda dated Oct. 1, 2020. 

Judge McCafferty indicated that the Barron trial may be conducted with technology that allows any parties to participate remotely, allowing for any issues related to the pandemic. Once plaintiffs and defendants have given their recommendations, the judge will rule on them.  

The next bellwether case will be Martha Luna’s case.

Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • Member of American Medical Writers Association (AMWA) and former Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine
Edited By

5 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. In Re: Atrium Medical Corp. C-Qur Mesh Products Liability Litigation. (2020, October 1). Plaintiffs’ and Defendants’ Joint Agenda For October 8, 2020 Status Conference. Retrieved from
  2. In Re: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation. (2020, August 14). Pretrial Order No. 18. Retrieved from
  3. In Re: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation. (2020, September 11). Evidentiary Motions Order No. 7, Plaintiff’s Motions to Exclude Dr. Novitsky and Dr. Renton. Retrieved from
  4. In Re: Ethicon Physiomesh Flexible Composite Hernia Mesh Products Liability Litigation. (2020, September 11). Practice And Procedure Order No. 24, Amended Discovery, Scheduling, and Case Management Order Governing Trial Cases. Retrieved from
  5. United States Judicial Panel on Multidistrict Litigation. (2020, October 15). MDL Statistics Report - Distribution of Pending MDL Dockets by District. Retrieved from
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(844) 807-8916